Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance

Noel A. Warfel

doi:10.1080/15384101.2017.1337975

Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance

Noel A. Warfel

Cellular & Molecular Medicine

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1241-1242
Number of pages	2
Journal	Cell Cycle
Volume	16
Issue number	13
DOIs	https://doi.org/10.1080/15384101.2017.1337975
State	Published - Jul 3 2017

ASJC Scopus subject areas

Molecular Biology
Developmental Biology
Cell Biology

Access to Document

10.1080/15384101.2017.1337975

Cite this

@article{e46887860729446abf5f7153626697e0,

title = "Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance",

author = "Warfel, \{Noel A.\}",

year = "2017",

month = jul,

day = "3",

doi = "10.1080/15384101.2017.1337975",

language = "English (US)",

volume = "16",

pages = "1241--1242",

journal = "Cell Cycle",

issn = "1538-4101",

publisher = "Taylor and Francis Ltd.",

number = "13",

}

TY - JOUR

T1 - Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance

AU - Warfel, Noel A.

PY - 2017/7/3

Y1 - 2017/7/3

UR - https://www.scopus.com/pages/publications/85021673954

UR - https://www.scopus.com/pages/publications/85021673954#tab=citedBy

U2 - 10.1080/15384101.2017.1337975

DO - 10.1080/15384101.2017.1337975

M3 - Comment/debate

C2 - 28594259

AN - SCOPUS:85021673954

SN - 1538-4101

VL - 16

SP - 1241

EP - 1242

JO - Cell Cycle

JF - Cell Cycle

IS - 13

ER -

Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this